A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Trial details
- Registry ID
- NCT07284758
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple MyelomaNCT07284758 | CCCC | Phase 2 | Recruiting | 2030-03Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |